ArticleCancer cell2015

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas.

Moshe Elkabets et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.